Author Correction: Selective Priming of Tumor Blood Vessels by Radiation Therapy Enhances Nanodrug Delivery.

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 09 2020
Historique:
entrez: 15 9 2020
pubmed: 16 9 2020
medline: 16 9 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41598-020-72253-7 PMID: 32929171 PMC: PMC7490694
pubmed: 32929171
doi: 10.1038/s41598-020-72253-7
pii: 10.1038/s41598-020-72253-7
pmc: PMC7490694
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

15344

Commentaires et corrections

Type : ErratumFor

Auteurs

Sijumon Kunjachan (S)

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States. sijumon@gmail.com.

Shady Kotb (S)

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.
Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS, Villeurbanne, France.

Robert Pola (R)

Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 16206, Prague 6, Czech Republic.

Michal Pechar (M)

Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 16206, Prague 6, Czech Republic.

Rajiv Kumar (R)

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.
Nanomedicine Science and Technology Center and Department of Physics, Northeastern University, Boston, MA, United States.

Bijay Singh (B)

Nanomedicine Science and Technology Center and Department of Physics, Northeastern University, Boston, MA, United States.

Felix Gremse (F)

Experimental Molecular Imaging, University Hospital and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.

Reza Taleeli (R)

Division of Medical Physics & Engineering, University of Texas Southwestern Medical Center, Texas, United States.

Florian Trichard (F)

Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS, Villeurbanne, France.

Vincent Motto-Ros (V)

Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS, Villeurbanne, France.

Lucie Sancey (L)

Institute for Advanced Biosciences, UGA/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France.

Alexandre Detappe (A)

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

Sayeda Yasmin-Karim (S)

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

Andrea Protti (A)

Lurie Family Imaging Center, Department of Radiology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

Ilanchezhian Shanmugam (I)

Nanomedicine Science and Technology Center and Department of Physics, Northeastern University, Boston, MA, United States.

Thomas Ireland (T)

LA-ICP-MS and ICP-ES Laboratories, Department of Earth and Environmental Sciences, Boston University, Boston, MA, United States.

Tomas Etrych (T)

Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Square 2, 16206, Prague 6, Czech Republic.

Srinivas Sridhar (S)

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.
Nanomedicine Science and Technology Center and Department of Physics, Northeastern University, Boston, MA, United States.

Olivier Tillement (O)

Institut Lumière Matière, UMR 5306, Université Claude Bernard Lyon 1, CNRS, Villeurbanne, France.

Mike Makrigiorgos (M)

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

Ross I Berbeco (RI)

Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States.

Classifications MeSH